UK markets closed

Atea Pharmaceuticals, Inc. (AVIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.7650-0.1250 (-3.21%)
As of 12:48PM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
143,823
188,460
764,375
850,117
-
Other short-term investments
434,283
458,249
0
-
-
Total cash
578,106
646,709
764,375
850,117
-
Other current assets
12,349
14,213
8,028
7,545
-
Total current assets
590,455
660,922
772,403
863,477
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
3,806
4,367
345
180
-
Accumulated depreciation
-689
-273
-161
-132
-
Net property, plant and equipment
3,117
4,094
184
48
-
Other long-term assets
1,396
1,692
305
107
-
Total non-current assets
4,513
5,786
489
155
-
Total assets
594,968
666,708
772,892
863,632
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
4,252
2,551
4,534
60
-
Taxes payable
0
99
2,572
0
-
Accrued liabilities
27,364
15,107
49,580
14,368
-
Deferred revenues
-
-
0
301,367
0
Total current liabilities
32,376
18,478
56,883
315,795
-
Non-current liabilities
Other long-term liabilities
-
-
5,932
36
95
Total non-current liabilities
7,400
7,658
5,932
36
-
Total liabilities
39,776
26,136
62,815
315,831
-
Stockholders' equity
Common stock
83
83
83
82
-
Retained earnings
-195,835
-59,879
56,030
-65,160
-
Accumulated other comprehensive income
207
-684
0
-
-
Total stockholders' equity
555,192
640,572
710,077
547,801
-
Total liabilities and stockholders' equity
594,968
666,708
772,892
863,632
-